72
Participants
Start Date
June 30, 2025
Primary Completion Date
August 3, 2027
Study Completion Date
January 30, 2029
Ivonescimab
20 mg/kg IV infusion every 3 weeks
FOLFOX regimen
oxaliplatin 85 mg/m² IV, leucovorin 200 mg/m² IV (or folinic acid 400 mg/m²), and fluorouracil (5-FU) 400 mg/m² IV bolus; followed by 5 FU 2400 mg/m² as a 46 hour continuous IV infusion, every 2 weeks
Cliniques universitaires Saint-Luc, Brussels
Institute Mutualiste Montsouris, Paris
Centre Eugène Marquis, Rennes
University College London, London
Collaborators (1)
Cancer Research UK & UCL Cancer Trials Centre
OTHER
Belgian Group of Digestive Oncology
OTHER
Summit Therapeutics
INDUSTRY
UNICANCER
OTHER